Vitamin D and Cancer Stem Cells in the Gastrointestinal Tract.

Abstract

Vitamin D has been widely used as a dietary supplement for the prevention and treatment of bone disorders. Epidemiological and preclinical studies demonstrated the anticancer action of vitamin D in a variety of cancers including those in the gastrointestinal (GI) tract. In these studies the inhibitory action of vitamin D on cancer stem cells (CSCs) has been a focus and is also an important subject to revolutionize the therapeutic potential of vitamin D on cancer treatment. Here, we summarize the involvement of CSC markers and factors and also their signaling pathways in the development of cancers in the esophagus, stomach, colon, pancreas and also liver. It is also evidenced that vitamin D could inhibit these markers and factors and their related signaling pathways to suppress tumor progression. All these information could provide new strategies in repurposing vitamin D as therapeutic agent to inhibit cancers in the GI tract.

• Authors: Ming-Xing Li, Long-Fei Li, Lin Zhang, Zan-Gang Xiao, Jing Shen, Wei Hu, Qiang Zeng, Chi-Hin Cho
• Journal: Current medicinal chemistry (Curr Med Chem) Vol. 24 Issue 9 Pg. 918-927 ( 2017) ISSN: 1875-533X [Electronic] United Arab Emirates
• PMID: 28201969 (Publication Type: Journal Article, Review)
• Copyright: Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Chemical References

• Vitamin D

Topics

• Gastrointestinal Tract (pathology)
• Humans
• Neoplastic Stem Cells (pathology)
• Tumor Microenvironment
• Vitamin D (physiology)